Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA.

Cancer Cell. 2006 May;9(5):391-403.

2.

Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.

Schulte A, Günther HS, Martens T, Zapf S, Riethdorf S, Wülfing C, Stoupiec M, Westphal M, Lamszus K.

Clin Cancer Res. 2012 Apr 1;18(7):1901-13. doi: 10.1158/1078-0432.CCR-11-3084. Epub 2012 Feb 7.

3.

Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility.

Bajetto A, Porcile C, Pattarozzi A, Scotti L, Aceto A, Daga A, Barbieri F, Florio T.

J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):143-54.

PMID:
23489694
4.

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.

Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K.

Oncogene. 2008 May 1;27(20):2897-909. Epub 2007 Nov 26.

PMID:
18037961
5.

Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.

Marfia G, Campanella R, Navone SE, Di Vito C, Riccitelli E, Hadi LA, Bornati A, de Rezende G, Giussani P, Tringali C, Viani P, Rampini P, Alessandri G, Parati E, Riboni L.

Glia. 2014 Dec;62(12):1968-81. doi: 10.1002/glia.22718. Epub 2014 Jul 5.

PMID:
25042636
6.

A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.

Schulte A, Günther HS, Phillips HS, Kemming D, Martens T, Kharbanda S, Soriano RH, Modrusan Z, Zapf S, Westphal M, Lamszus K.

Glia. 2011 Apr;59(4):590-602. doi: 10.1002/glia.21127. Epub 2011 Feb 3.

PMID:
21294158
7.

An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours.

Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, Watts C.

J Neurosci Methods. 2009 Jan 30;176(2):192-9. doi: 10.1016/j.jneumeth.2008.07.022.

PMID:
19215724
8.

Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas.

Li A, Walling J, Kotliarov Y, Center A, Steed ME, Ahn SJ, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA.

Mol Cancer Res. 2008 Jan;6(1):21-30. doi: 10.1158/1541-7786.MCR-07-0280. Epub 2008 Jan 9.

9.

Autocrine factors sustain glioblastoma stem cell self-renewal.

Li G, Chen Z, Hu YD, Wei H, Li D, Ji H, Wang DL.

Oncol Rep. 2009 Feb;21(2):419-24.

PMID:
19148517
10.

A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.

Visnyei K, Onodera H, Damoiseaux R, Saigusa K, Petrosyan S, De Vries D, Ferrari D, Saxe J, Panosyan EH, Masterman-Smith M, Mottahedeh J, Bradley KA, Huang J, Sabatti C, Nakano I, Kornblum HI.

Mol Cancer Ther. 2011 Oct;10(10):1818-28. doi: 10.1158/1535-7163.MCT-11-0268. Epub 2011 Aug 22.

11.

Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions.

Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J, Murrell W, Langmoen IA.

Neuro Oncol. 2010 Dec;12(12):1220-30. doi: 10.1093/neuonc/noq102. Epub 2010 Sep 14.

12.

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile.

Hägerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, Nistér M.

Neuro Oncol. 2011 Nov;13(11):1178-91. doi: 10.1093/neuonc/nor113. Epub 2011 Sep 22.

13.

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.

Anaka M, Freyer C, Gedye C, Caballero O, Davis ID, Behren A, Cebon J.

Stem Cells. 2012 Feb;30(2):336-43. doi: 10.1002/stem.786.

14.

Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.

Gatti M, Pattarozzi A, Bajetto A, Würth R, Daga A, Fiaschi P, Zona G, Florio T, Barbieri F.

Toxicology. 2013 Dec 15;314(2-3):209-20. doi: 10.1016/j.tox.2013.10.003. Epub 2013 Oct 21.

PMID:
24157575
15.

Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.

Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF, McConnell MJ.

Stem Cells. 2011 Mar;29(3):452-61. doi: 10.1002/stem.582.

16.

Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics.

Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A.

Sci Rep. 2013;3:1095. doi: 10.1038/srep01095. Epub 2013 Feb 5.

17.

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A.

Cancer Res. 2004 Oct 1;64(19):7011-21.

18.

The MET oncogene is a functional marker of a glioblastoma stem cell subtype.

De Bacco F, Casanova E, Medico E, Pellegatta S, Orzan F, Albano R, Luraghi P, Reato G, D'Ambrosio A, Porrati P, Patanè M, Maderna E, Pollo B, Comoglio PM, Finocchiaro G, Boccaccio C.

Cancer Res. 2012 Sep 1;72(17):4537-50. doi: 10.1158/0008-5472.CAN-11-3490. Epub 2012 Jun 26.

19.
20.

Isolation and culture of primary glioblastoma cells from human tumor specimens.

Seidel S, Garvalov BK, Acker T.

Methods Mol Biol. 2015;1235:263-75. doi: 10.1007/978-1-4939-1785-3_19.

PMID:
25388399

Supplemental Content

Support Center